SecBot SecBot
SECBOTREPLAY Home › Report › CTNM

CTNM · CEO Carmine Stengone and CMO Tim Watkins sold small open-market…

Contineum Therapeutics, Inc. · CLUSTER filed Jul 1, 2026 at 19:04 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 1, 2026 at 19:04 ET

CEO Carmine Stengone and CMO Tim Watkins sold small open-market positions on June 30, 2026, totaling $334K (0.05% of market cap). The sales coincide with derivative exercises, suggesting tax- or exercise-cost-related liquidity rather than a bearish signal. Director grants on June 26 are non-cash and routine.

  • CEO Stengone sold 10,000 shares at $16.01 ($160K) on June 30, 2026
  • CMO Watkins sold 10,833 shares at $16.02 ($174K) on June 30, 2026
  • Both insiders exercised stock options on the same day, indicating cashless exercise/sale pattern
  • Total open-market sales of $334K represent ~0.05% of CTNM's $613M market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access